It is a highly successful method of weight loss for a variety of reasons
In clinical trials, non-diabetic individuals taking semaglutide experienced significant weight loss, with average weight loss ranging from 10% to 15% of initial body weight over 6-12 months of treatment
Microdosing GLP-1s: Reduce Inflammation, Support Cognitive Health The potential of microdosing GLP-1 for weight loss, inflammation, cognitive health, and more
Metformin Metformin isnt considered a primary weight loss medication, but some studies suggest it may lead to modest, clinically meaningful weight reduction in certain groups
At MedHealth 360, our expert team has a deep understanding of functional medicine, precision dosing, and patient safety